ConductScience.org, home
MYCL: MYCL proto-oncogene, bHLH transcription factor
API referenceFor AI assistants

Gene · 4610

Papers2,575

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

21 to 40 of 2,575

Download this page as JSON
TitleJournalYearPMIDFound bySource
Mechanism of interaction between the transactivation domain of N-myc and the DNA-binding surface of TFIIIC5.Nucleic Acids Res202641755638PubTator, text miningPubMed
In Vitro Anticancer Activity and In Silico Target Profiling of 5-(Piperazin-1-ylsulfonyl)-1,3-oxazole-4-carbonitriles.Int J Mol Sci202641752072PubTator, text miningPubMed
Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer.J Natl Cancer Cent202641738031PubTator, text miningPubMed
A Case of IDH-Mutant Astrocytoma Harboring an IDH2 R172_H173delinsSN Variant.Neuropathology202641736408PubTator, text miningPubMed
Eukaryote initiation factor 6 modulates small-cell lung carcinoma plasticity via the integrin-FAK signaling axis.Nat Commun202641735293PubTator, text miningPubMed
The N-Myc MB0-MBI region interacts specifically and dynamically with the N-lobe of Aurora kinase A.Nat Commun202641735282PubTator, text miningPubMed
Primary pulmonary histiocytic sarcoma with CNS metastasis: a case report and molecular profiling insights.Front Oncol202641727642PubTator, text miningPubMed
The Role of PDE3A in Cancer.ACS Omega202641726589PubTator, text miningPubMed
CASPR2 Autoimmune Antibodies Induce Neuronal Hyperactivity in Human Brain Organoids.J Neurochem202641725505PubTator, text miningPubMed
CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness.Cell Death Dis202641714328PubTator, text miningPubMed
Harnessing PDX and PDX 2.0: the next-generation paradigm for precision oncology and translational breakthroughs.Mol Cancer202641699647PubTator, text miningPubMed
Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.Cancer Immunol Res202641666253PubTator, text miningPubMed
Obesity- and tumor-derived signals drive cancer-associated state transitions in breast mesenchymal stromal/stem cells reprogrammed by IL1RA or JAK inhibition.Exp Hematol Oncol202641645323PubTator, text miningPubMed
CDK2 inhibition promotes neuronal differentiation in neuroblastoma.Sci Rep202641644599PubTator, text miningPubMed
Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune responses.Alzheimers Dement202641639038PubTator, text miningPubMed
Circ_0001839 modulates the oncogenic MYCL rs1038259890 (p.G83S) mutation to promote B[a]P-induced malignant transformation in 16HBE cells.J Hazard Mater202641619596PubTator, text miningPubMed
ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin.Mol Cancer Ther202641582485PubTator, text miningPubMed
c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors.Cell Rep Med202641564857PubTator, text miningPubMed
Emerging frontiers in the mitochondrial regulation of dendritic cell biology.Redox Biol202641564795PubTator, text miningPubMed
Combining anti-gene γPNA with small molecules and RNA inhibitors: A strategy to enhance anti-tumor efficacy.Mol Ther Nucleic Acids202641536812PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4610/papers?page=2

API referenceFor AI assistants